Matthis Geitmann
Impact in
- Virology top 5%
- HIV Research and Treatment
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Epigenetics and DNA Methylation 5
- Nicotinic Acetylcholine Receptors Study 4
- Histone Deacetylase Inhibitors Research 4
- Cancer-related gene regulation 3
- Chemical Synthesis and Analysis 3
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- U. Helena Danielson (22 shared papers)Torsten Unge (2 shared papers)Iwan J. P. de Esch (4 shared papers)August B. Smit (4 shared papers)Amorn Petsom (1 shared paper)Peter Brandt (5 shared papers)Sophon Roengsumran (1 shared paper)Kim Retra (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Cancer Research (4 papers)SLAS DISCOVERY (2 papers)Analytical Biochemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Matthis Geitmann
27 papers receiving 736 citations
Peers
Comparison fields: 5 of 82
- Virology 81
- Hepatology 64
- Molecular Biology 504
- Pharmacology 57
- Infectious Diseases 102
Countries citing papers authored by Matthis Geitmann
This map shows the geographic impact of Matthis Geitmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthis Geitmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthis Geitmann more than expected).
Fields of papers citing papers by Matthis Geitmann
This network shows the impact of papers produced by Matthis Geitmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthis Geitmann. The network helps show where Matthis Geitmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthis Geitmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 96 | |
| 2 | 2009 | 74 | |
| 3 | 2012 | 68 | |
| 4 | Inhibition of viral proteases by Zingiberaceae extracts and flavones isolated from Kaempferia parviflora. | 2006 | 58 |
| 5 | 2009 | 57 | |
| 6 | 2017 | 42 | |
| 7 | 2006 | 41 | |
| 8 | 2011 | 37 | |
| 9 | 2010 | 34 | |
| 10 | 2004 | 34 | |
| 11 | 2006 | 30 | |
| 12 | 2010 | 28 | |
| 13 | 2010 | 26 | |
| 14 | 2020 | 20 | |
| 15 | 2011 | 16 | |
| 16 | 2007 | 15 | |
| 17 | 2010 | 13 | |
| 18 | 2017 | 13 | |
| 19 | 2009 | 11 | |
| 20 | 2017 | 10 |
About Matthis Geitmann
Matthis Geitmann is a scholar working on Molecular Biology, Infectious Diseases, Virology, Epidemiology and Organic Chemistry, having authored 30 papers that have together received 752 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Epigenetics and DNA Methylation (5 papers), HIV Research and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer-related gene regulation (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Virology (81 citations), Hepatology (64 citations), Molecular Biology (504 citations), Pharmacology (57 citations) and Infectious Diseases (102 citations). Matthis Geitmann has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include U. Helena Danielson, Torsten Unge, Iwan J. P. de Esch, August B. Smit, Amorn Petsom, Peter Brandt, Sophon Roengsumran, Kim Retra, René van Elk and Oliver Wicht. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, SLAS DISCOVERY, Analytical Biochemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.